Press releases
- Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
- Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
- Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance
- Tandem Diabetes Care Launches Tandem Mobi, the World’s Smallest, Durable Automated Insulin Delivery System
- Tandem Diabetes Care Announces Upcoming Conference Presentations
More ▼
Key statistics
As of last trade Tandem Diabetes Care Inc (0M0F:LSE) traded at 35.05, -8.41% below its 52-week high of 38.27, set on Apr 28, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 35.05 |
Average volume | 354.00 |
---|---|
Shares outstanding | 65.63m |
Free float | 65.21m |
P/E (TTM) | -- |
Market cap | 2.30bn USD |
EPS (TTM) | -3.44 USD |
Data delayed at least 20 minutes, as of Apr 24 2024 19:04 BST.
More ▼